Coprosterol

Coprosterol is a lipid of Sterol Lipids (ST) class. Coprosterol is associated with abnormalities such as Cerebrovascular accident, Glycogen Storage Disease Type IV, Coronary Arteriosclerosis, CARDIAC EVENT and Diabetes Mellitus, Non-Insulin-Dependent. The involved functions are known as cholesterol absorption, Death, Sudden, Cardiac, Drug Interactions, Cholesterol Homeostasis and Synthesis. Coprosterol often locates in lipid raft, Tissue membrane, Membrane, Blood and Body tissue. The associated genes with Coprosterol are ABO gene, STN gene, Alleles, Apolipoprotein E gene and TNF gene. The related lipids are saturated fat, campesterol, lathosterol, Sterols and Total cholesterol. The related experimental models are Rodent Model.

Cross Reference

Introduction

To understand associated biological information of Coprosterol, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Coprosterol?

Coprosterol is suspected in Coronary Arteriosclerosis, Cerebrovascular accident, Glycogen Storage Disease Type IV, CARDIAC EVENT, Diabetes Mellitus, Non-Insulin-Dependent, Niemann-Pick Diseases and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Coprosterol

MeSH term MeSH ID Detail
Brain Diseases, Metabolic D001928 9 associated lipids
Biliary Fistula D001658 13 associated lipids
Xanthomatosis, Cerebrotendinous D019294 14 associated lipids
Xanthomatosis D014973 17 associated lipids
Alcoholism D000437 27 associated lipids
Cataract D002386 34 associated lipids
Diabetes Mellitus, Type 2 D003924 87 associated lipids
Diabetes Mellitus D003920 90 associated lipids
Hypercholesterolemia D006937 91 associated lipids
Total 9

PubChem Associated disorders and diseases

What pathways are associated with Coprosterol

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Coprosterol?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Coprosterol?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Coprosterol?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Coprosterol?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Coprosterol?

Rodent Model

Rodent Model are used in the study 'Formation of 7-dehydrocholesterol-containing membrane rafts in vitro and in vivo, with relevance to the Smith-Lemli-Opitz syndrome.' (Keller RK et al., 2004).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Coprosterol

Download all related citations
Per page 10 20 50 100 | Total 485
Authors Title Published Journal PubMed Link
WELLS WW Coprostanol formation. I. The effect of sodium taurocholate and Tween 80 on the sterol composition of rat feces. 1957 Arch. Biochem. Biophys. pmid:13395541
WELLS WW and COOPER SB Coprostanol formation. II. The opposing action of dietary lactose and calcium on cholesterol absorption. 1958 Arch. Biochem. Biophys. pmid:13534706
MOSBACH EH and BEVANS M Formation of gall stones in rabbits fed 3beta-cholestanol. 1956 Arch. Biochem. Biophys. pmid:13341064
Moghadasian MH et al. Cerebrotendinous xanthomatosis: a rare disease with diverse manifestations. 2002 Arch. Neurol. pmid:11939886
Verrips A et al. Presence of diarrhea and absence of tendon xanthomas in patients with cerebrotendinous xanthomatosis. 2000 Arch. Neurol. pmid:10768627
Katz DA et al. Peripheral neuropathy in cerebrotendinous xanthomatosis. 1985 Arch. Neurol. pmid:2994606
Monson DM et al. Cerebrotendinous xanthomatosis: a treatable disease with juvenile cataracts as a presenting sign. 2011 Arch. Ophthalmol. pmid:21825196
Tészás A et al. Presenile cataract: consider cholestanol. 2006 Arch. Ophthalmol. pmid:17030721
Miettinen TA et al. Noncholesterol sterols and cholesterol lowering by long-term simvastatin treatment in coronary patients: relation to basal serum cholestanol. 2000 Arterioscler. Thromb. Vasc. Biol. pmid:10807752
van Himbergen TM et al. Familial combined hyperlipidemia is associated with alterations in the cholesterol synthesis pathway. 2010 Arterioscler. Thromb. Vasc. Biol. pmid:19834104
von Bahr S et al. Mechanism of accumulation of cholesterol and cholestanol in tendons and the role of sterol 27-hydroxylase (CYP27A1). 2002 Arterioscler. Thromb. Vasc. Biol. pmid:12117727
Gylling H and Miettinen TA Baseline intestinal absorption and synthesis of cholesterol regulate its response to hypolipidaemic treatments in coronary patients. 2002 Atherosclerosis pmid:11849674
Miettinen TA and Gylling H Ineffective decrease of serum cholesterol by simvastatin in a subgroup of hypercholesterolemic coronary patients. 2002 Atherosclerosis pmid:12119203
Wang X et al. Plasma cholesterol-lowering activity of dietary dihydrocholesterol in hypercholesterolemia hamsters. 2015 Atherosclerosis pmid:26184696
Sittiwet C et al. Cholesterol metabolism and non-cholesterol sterol distribution in lipoproteins of type 1 diabetes: the effect of improved glycemic control. 2007 Atherosclerosis pmid:16996519
Vanhanen HT and Miettinen TA Cholesterol absorption and synthesis during pravastatin, gemfibrozil and their combination. 1995 Atherosclerosis pmid:7661873
Hoenig MR et al. Cholestanol: a serum marker to guide LDL cholesterol-lowering therapy. 2006 Atherosclerosis pmid:16216250
Miettinen TA et al. Relation of non-cholesterol sterols to coronary risk factors and carotid intima-media thickness: the Cardiovascular Risk in Young Finns Study. 2010 Atherosclerosis pmid:19963215
Niesor EJ et al. Effect of dalcetrapib, a CETP modulator, on non-cholesterol sterol markers of cholesterol homeostasis in healthy subjects. 2011 Atherosclerosis pmid:21982411
Takashima K et al. The hypocholesterolemic action of TA-7552 and its effects on cholesterol metabolism in the rat. 1994 Atherosclerosis pmid:7980699
Miettinen TA et al. Synthesis and absorption of cholesterol in Finnish boys by serum non-cholesterol sterols: the cardiovascular risk in Young Finns Study. 2008 Atherosclerosis pmid:18178213
Björkhem I and Hansson M Cerebrotendinous xanthomatosis: an inborn error in bile acid synthesis with defined mutations but still a challenge. 2010 Biochem. Biophys. Res. Commun. pmid:20494109
Rodriguez RJ et al. A requirement for ergosterol to permit growth of yeast sterol auxotrophs on cholestanol. 1982 Biochem. Biophys. Res. Commun. pmid:6809003
Inoue K et al. Cholestanol induces apoptosis of cerebellar neuronal cells. 1999 Biochem. Biophys. Res. Commun. pmid:10066446
GERSON T The determination of cholesterol and coprosterol in faecal lipids. 1960 Biochem. J. pmid:13704757
Smith AG et al. The intermediacy of 3-oxo steroids in the conversion of cholest-5-en-3 -ol into 5 -cholestan-3 -ol by the starfish Asterias rubens and Porania pulvillus. 1972 Biochem. J. pmid:4566194
Contreras LM et al. Altered lipid composition and enzyme activities of plasma membranes from Trypanosoma (Schizotrypanum) cruzi epimastigotes grown in the presence of sterol biosynthesis inhibitors. 1997 Biochem. Pharmacol. pmid:9113089
Kim KS et al. Effects of cholestanol feeding on corneal dystrophy in mice. 1991 Biochim. Biophys. Acta pmid:1911869
Okonogi TM et al. Two fatty acids can replace one phospholipid in condensed complexes with cholesterol. 2002 Biochim. Biophys. Acta pmid:12100988
Norman AW et al. Studies on the biological properties of polyene antibiotics: comparison of other polyenes with filipin in their ability to interact specifically with sterol. 1972 Biochim. Biophys. Acta pmid:4565643
Björkhem I et al. Isolation of 5 alpha-cholestane-3 beta, 7 alpha-diol from bile of patients with cerebrotendinous xanthomatosis. Inefficiency of this steroid as a precursor to cholestanol. 1983 Biochim. Biophys. Acta pmid:6412759
Rosetti CM et al. Micron-scale phase segregation in lipid monolayers induced by myelin basic protein in the presence of a cholesterol analog. 2010 Biochim. Biophys. Acta pmid:19914203
Szalat A et al. Rifampicin-induced CYP3A4 activation in CTX patients cannot replace chenodeoxycholic acid treatment. 2007 Biochim. Biophys. Acta pmid:17553741
AZARNOFF DL and TUCKER DR SEPARATION OF NUCLEAR SATURATED FROM UNSATURATED STEROLS. 1963 Biochim. Biophys. Acta pmid:14085943
Ghosh D and Tinoco J Monolayer interactions of individual lecithins with natural sterols. 1972 Biochim. Biophys. Acta pmid:4557356
Hagen JP and McConnell HM Critical pressures in multicomponent lipid monolayers. 1996 Biochim. Biophys. Acta pmid:8639690
Schubert K and Kaufmann G [Formation of sterol esters in bacterial cells]. 1965 Biochim. Biophys. Acta pmid:5326537
Björkhem I et al. On the structural specificity in the regulation of the hydroxymethylglutaryl-CoA reductase and the cholesterol-7 alpha-hydroxylase in rats. Effects of cholestanol feeding. 1985 Biochim. Biophys. Acta pmid:3924107
Addona GH et al. Low chemical specificity of the nicotinic acetylcholine receptor sterol activation site. 2003 Biochim. Biophys. Acta pmid:12543379
Hagen JP and McConnell HM Liquid-liquid immiscibility in lipid monolayers. 1997 Biochim. Biophys. Acta pmid:9370239
Gerasimov OV et al. Acid-catalyzed plasmenylcholine hydrolysis and its effect on bilayer permeability: a quantitative study. 1997 Biochim. Biophys. Acta pmid:9092707
Rothblat GH and Kritchevsky D The excretion of free and ester cholesterol by tissue culture cells: studies with L5178Y and L-cells. 1967 Biochim. Biophys. Acta pmid:4863609
de Medina P et al. Technical note: Hapten synthesis, antibody production and development of an enzyme-linked immunosorbent assay for detection of the natural steroidal alkaloid Dendrogenin A. 2013 Biochimie pmid:22709869
Nimmo MR and Cross NL Structural features of sterols required to inhibit human sperm capacitation. 2003 Biol. Reprod. pmid:12606419
Hojo K et al. Determination of serum cholestanol by semi-micro high-performance liquid chromatography with electrochemical detection. 2010 Biomed. Chromatogr. pmid:19795364
Beattie ME et al. Sterol structure determines miscibility versus melting transitions in lipid vesicles. 2005 Biophys. J. pmid:15951379
Ratajczak MK et al. Cholesterol displacement from membrane phospholipids by hexadecanol. 2007 Biophys. J. pmid:17526582
Hu Y et al. Thermodynamic equilibrium of domains in a two-component Langmuir monolayer. 2006 Biophys. J. pmid:16632506
Radhakrishnan A and McConnell HM Condensed complexes of cholesterol and phospholipids. 1999 Biophys. J. pmid:10465761
Stottrup BL and Keller SL Phase behavior of lipid monolayers containing DPPC and cholesterol analogs. 2006 Biophys. J. pmid:16461392